Pfizer–BioNTech
E335285
Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
All labels observed (6)
| Label | Occurrences |
|---|---|
| Comirnaty | 2 |
| Pfizer–BioNTech COVID-19 vaccine | 2 |
| Pfizer and BioNTech SE | 1 |
| Pfizer–BioNTech canonical | 1 |
| Pfizer–BioNTech COVID-19 vaccine collaboration | 1 |
| Pfizer–BioNTech COVID‑19 vaccine | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T3205347 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Pfizer–BioNTech Context triple: [COVID-19 pandemic, majorVaccineDeveloper, Pfizer–BioNTech]
-
A.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
B.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
C.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
D.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
E.
Janssen Biotech
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Pfizer–BioNTech Target entity description: Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
-
A.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
B.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
C.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
D.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
E.
Janssen Biotech
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
- F. None of above. chosen
Statements (43)
| Predicate | Object |
|---|---|
| instanceOf |
pharmaceutical partnership
ⓘ
strategic alliance ⓘ |
| clinicalTrialPhase3Sponsor |
BioNTech SE
ⓘ
linked to:
BioNTech
Pfizer ⓘ |
| developed |
BNT162b2
ⓘ
Pfizer–BioNTech COVID‑19 vaccine ⓘ
linked to:
BNT162b2
|
| doseRegimen | two‑dose primary series ⓘ |
| focusesOn |
COVID‑19 vaccine development
ⓘ
infectious disease prevention ⓘ |
| geographicScope | global ⓘ |
| hasBoosterFormulations | true ⓘ |
| hasColdChainRequirement | ultra‑low temperature storage ⓘ |
| hasManufacturingPartner | Pfizer ⓘ |
| hasParticipant |
BioNTech SE
ⓘ
linked to:
BioNTech
Pfizer ⓘ |
| hasRegulatoryApprovalFor |
Pfizer–BioNTech COVID‑19 vaccine
ⓘ
linked to:
BNT162b2
|
| hasRegulatoryDesignation | first mRNA vaccine to receive widespread authorization against COVID‑19 ⓘ |
| hasRegulatoryPathway |
Emergency Use Authorization
ⓘ
full marketing authorization ⓘ |
| hasResearchPartner |
BioNTech SE
ⓘ
linked to:
BioNTech
|
| hasVariantSpecificFormulations | Omicron‑adapted COVID‑19 vaccine ⓘ |
| industry |
biotechnology industry
ⓘ
pharmaceutical industry ⓘ |
| isCommercialCollaborationBetween |
Pfizer and BioNTech SE
ⓘ
linked to:
Pfizer–BioNTech
|
| isFirstWidelyAuthorizedMRNAVaccineDeveloper | true ⓘ |
| majorMarket |
Canada
ⓘ
European Union ⓘ Japan ⓘ United Kingdom ⓘ United States ⓘ
linked to:
United States of America
|
| notableWork | BNT162b2 ⓘ |
| primaryIndication | prevention of COVID‑19 ⓘ |
| productBrandName | Comirnaty ⓘ |
| publicHealthImpact | mass vaccination campaigns against COVID‑19 ⓘ |
| receivedEmergencyUseAuthorizationFor |
Pfizer–BioNTech COVID‑19 vaccine
ⓘ
linked to:
Pfizer–BioNTech
|
| receivedEmergencyUseAuthorizationFrom |
European Medicines Agency
ⓘ
U.S. Food and Drug Administration ⓘ
linked to:
Food and Drug Administration
World Health Organization ⓘ |
| targetPathogen |
SARS‑CoV‑2
ⓘ
linked to:
SARS-CoV-2
|
| technologyUsed |
lipid nanoparticle delivery system
ⓘ
messenger RNA ⓘ |
| usesPlatform | BioNTech mRNA platform ⓘ |
| vaccineType | mRNA vaccine ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Pfizer–BioNTech Description of subject: Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
Referenced by (8)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject linked to:
Karikó
linked to: Pfizer–BioNTech
linked to: Pfizer–BioNTech
linked to: Pfizer–BioNTech